Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potent morphiceptin analogs: structure activity relationships and morphine-like activities.

K J Chang, E T Wei, A Killian

    The Journal of Pharmacology and Experimental Therapeutics
    |November 1, 1983
    PubMed
    Summary

    Researchers modified morphiceptin to create potent mu-opioid receptor agonists. The analog Tyr-Pro-NMePhe-D-Pro-NH2 (PL017) demonstrated significant analgesic effects in vivo, reversible by naloxone.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Clinical efficacy of transcatheter edge-to-edge repair in patients with non-central degenerative mitral regurgitation].

    Zhonghua xin xue guan bing za zhi·2025
    Same author

    [Mid- and long-term outcomes of percutaneous balloon mitral valvuloplasty guided solely by echocardiography].

    Zhonghua yi xue za zhi·2024
    Same author

    TRPM8 agonist (cryosim-1) gel for scalp itch: a randomised, vehicle-controlled clinical trial.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2022
    Same author

    [The mechanism of HOTAIR regulating the proliferation and apoptosis of prostate cancer cells by targeting down-regulation of miR-152 to improve the expression of FOXR2].

    Zhonghua yi xue za zhi·2019
    Same author

    GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems.

    Journal of dental research·2018
    Same author

    Genome-wide association analyses reveal complex genetic architecture underlying natural variation for flowering time in canola.

    Plant, cell & environment·2015

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Neuroscience

    Background:

    • Morphiceptin is a selective mu-opioid receptor agonist.
    • Opioid receptor ligands are crucial for pain management.
    • Developing selective agonists with improved properties is an ongoing goal.

    Purpose of the Study:

    • To synthesize and characterize novel morphiceptin analogs.
    • To investigate the structure-activity relationships of morphiceptin at mu and delta opioid receptors.
    • To evaluate the analgesic potential of promising analogs in vivo.

    Main Methods:

    • Chemical synthesis of morphiceptin analogs with substitutions at key residues.
    • In vitro receptor binding assays using radiolabeled ligands for mu and delta opioid receptors.

    Related Experiment Videos

  • Ex vivo functional assays measuring smooth muscle contraction in mouse vas deferens and guinea-pig ileum.
  • In vivo analgesic testing in rats following central administration.

    • Main Results:

    • All synthesized analogs exhibited minimal activity at delta opioid receptors.
    • Specific modifications, including N-methylation of phenylalanine and D-proline substitution, yielded potent mu-agonists, notably Tyr-Pro-NMePhe-D-Pro-NH2 (PL017).
    • In vitro and ex vivo data showed strong correlations between mu receptor binding and functional activity, indicating mu receptor mediation.
    • In vivo studies demonstrated long-lasting, naloxone-reversible analgesia in rats following central administration of PL017.

    Conclusions:

    • Structural modifications of morphiceptin can generate highly selective and potent mu-opioid receptor agonists.
    • PL017 represents a promising lead compound for developing novel analgesics targeting the mu-opioid receptor.
    • The study validates the role of mu-opioid receptors in mediating the observed analgesic effects.